Published in Proc Natl Acad Sci U S A on December 08, 1998
Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ (2011) 3.18
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol (2011) 3.02
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev (2012) 2.22
Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 2.08
Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 1.84
Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci U S A (1999) 1.68
Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab (2008) 1.65
Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol (2013) 1.60
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet (2011) 1.51
Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab (2002) 1.47
Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome. Proc Natl Acad Sci U S A (2006) 1.38
Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome. Mol Cell Endocrinol (2011) 1.38
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype. Proc Natl Acad Sci U S A (2014) 1.28
Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome. Metabolism (2008) 1.20
Transient prenatal androgen exposure produces metabolic syndrome in adult female rats. Am J Physiol Endocrinol Metab (2008) 1.20
Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J Clin Endocrinol Metab (2012) 1.19
Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 1.17
Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J Clin Endocrinol Metab (2009) 1.17
FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS One (2011) 1.16
Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun (2015) 1.14
Prenatal androgen exposure programs metabolic dysfunction in female mice. J Endocrinol (2010) 1.13
Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2002) 1.12
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev (2015) 1.06
The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome. Metabolism (2007) 1.00
Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.98
Genetics of the polycystic ovary syndrome. Mol Cell Endocrinol (2012) 0.97
High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. J Clin Endocrinol Metab (2009) 0.95
Contemporary genetic technologies and female reproduction. Hum Reprod Update (2011) 0.95
Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives. J Clin Endocrinol Metab (2009) 0.95
Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 0.94
Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care (2008) 0.93
Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.93
Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am (2005) 0.93
Polycystic ovary syndrome in the pediatric population. Metab Syndr Relat Disord (2010) 0.93
Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril (2010) 0.92
Nonhuman primate models of polycystic ovary syndrome. Mol Cell Endocrinol (2013) 0.91
Poly Cystic Ovarian Syndrome: An Updated Overview. Front Physiol (2016) 0.90
Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab (2013) 0.90
State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS). Int J Pediatr Endocrinol (2011) 0.90
Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. Fertil Steril (2006) 0.89
The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol (2014) 0.88
Persistence pays off for PCOS gene prospectors. J Clin Endocrinol Metab (2012) 0.87
Prenatal testosterone exposure leads to hypertension that is gonadal hormone-dependent in adult rat male and female offspring. Biol Reprod (2012) 0.87
Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol Metab (2015) 0.86
Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. Fertil Steril (2011) 0.86
Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed) (2014) 0.86
Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study. Fertil Steril (2011) 0.86
Ovarian hypertension: polycystic ovary syndrome. Endocrinol Metab Clin North Am (2011) 0.85
Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects. Diabetologia (2007) 0.84
Family association study between INSR gene polymorphisms and PCOS in Han Chinese. Reprod Biol Endocrinol (2011) 0.84
Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome. Hum Reprod (2011) 0.84
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev (2016) 0.83
FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome. Hum Reprod (2008) 0.83
Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids (2011) 0.83
A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome. Fertil Steril (2010) 0.83
Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome. PLoS One (2012) 0.83
PDE8A genetic variation, polycystic ovary syndrome and androgen levels in women. Mol Hum Reprod (2009) 0.83
Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine (2012) 0.82
Intrauterine environment and polycystic ovary syndrome. Semin Reprod Med (2014) 0.82
Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2011) 0.82
Phosphorylation of human cytochrome P450c17 by p38α selectively increases 17,20 lyase activity and androgen biosynthesis. J Biol Chem (2013) 0.82
Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity. J Clin Endocrinol Metab (2016) 0.81
Pathway Analysis Based on a Genome-Wide Association Study of Polycystic Ovary Syndrome. PLoS One (2015) 0.81
Interventional studies for polycystic ovarian syndrome in children and adolescents. Ped Health (2010) 0.81
Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab (2016) 0.81
The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma. PPAR Res (2007) 0.80
Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. J Clin Endocrinol Metab (2012) 0.80
Lipidomic analysis of plasma samples from women with polycystic ovary syndrome. Metabolomics (2014) 0.79
A meta-analysis on the association between PPAR-γ Pro12Ala polymorphism and polycystic ovary syndrome. J Assist Reprod Genet (2012) 0.79
Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome. Diabetes Res Clin Pract (2009) 0.79
Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome. Ther Clin Risk Manag (2008) 0.79
Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome. Fertil Steril (2012) 0.79
A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice. Biol Reprod (2015) 0.78
Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome. Hum Reprod (2014) 0.78
The role of genetic variation in the lamin a/c gene in the etiology of polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 0.78
Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage. Mol Hum Reprod (2012) 0.78
Effect of maternal PCOS and PCOS-like phenotype on the offspring's health. Mol Cell Endocrinol (2015) 0.78
Persistent apparent pancreatic β-cell defects in premenarchal PCOS relatives. J Clin Endocrinol Metab (2014) 0.78
Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome. PLoS One (2011) 0.78
Polycystic ovary syndrome (PCOS): metformin. BMJ Clin Evid (2015) 0.77
Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India. Indian J Endocrinol Metab (2014) 0.77
The therapy of insulin resistance in other diseases besides type 2 diabetes. Eat Weight Disord (2014) 0.77
Does PCOS have developmental origins? Fertil Steril (2012) 0.77
Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome. Int J Pediatr Endocrinol (2012) 0.77
Negative association of acetate with visceral adipose tissue and insulin levels. Diabetes Metab Syndr Obes (2012) 0.77
Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome. J Clin Endocrinol Metab (2014) 0.76
Association between follicular fluid leptin and serum insulin levels in nonoverweight women with polycystic ovary syndrome. Biomed Res Int (2014) 0.76
The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome. J Clin Endocrinol Metab (2014) 0.76
Association of fibrillin-3 and transcription factor-7-like 2 gene variants with metabolic phenotypes in PCOS. Obesity (Silver Spring) (2012) 0.76
Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters. Clin Endocrinol (Oxf) (2011) 0.76
No association between the microsatellite polymorphism (TTTTA)n in the promoter of the CYP11A gene and ovarian hyperstimulation syndrome. J Assist Reprod Genet (2006) 0.75
Diagnosis and treatment of polycystic ovary syndrome (PCOS): an interview with Richard Legro. BMC Med (2015) 0.75
Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertil Steril (2016) 0.75
Normal Pubertal Development in Daughters of Women with PCOS: A Controlled Study. J Clin Endocrinol Metab (2016) 0.75
Association study of androgen signaling pathway genes in polycystic ovary syndrome. Fertil Steril (2015) 0.75
[Study of clinical, sonographic and nutritional aspects of polycystic ovary syndrome (PCOS) in Mbuji-Mayi, DR Congo]. Pan Afr Med J (2014) 0.75
Alternative splicing of DENND1A, a PCOS candidate gene, generates variant 2. Mol Cell Endocrinol (2016) 0.75
Assessment of growth and metabolism characteristics in offspring of dehydroepiandrosterone-induced polycystic ovary syndrome adults. Reproduction (2016) 0.75
Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome. Hum Reprod (2012) 0.75
PCOS. BMJ Clin Evid (2009) 0.75
Genetic dissection of complex traits. Science (1994) 29.54
Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev (1997) 5.83
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab (1998) 4.63
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) (1986) 3.14
Hirsutism: implications, etiology, and management. Am J Obstet Gynecol (1981) 2.92
Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med (1996) 2.77
Polycystic ovaries--a common finding in normal women. Lancet (1988) 2.58
Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms. J Clin Invest (1973) 2.23
Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet (1986) 2.14
Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. Am J Hum Genet (1977) 1.94
The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab (1996) 1.80
Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception (1974) 1.66
Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev (1995) 1.63
Genetic analysis of NIDDM. The study of quantitative traits. Diabetes (1996) 1.40
The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust N Z J Obstet Gynaecol (1994) 1.29
The genetic basis of polycystic ovary syndrome. Hum Reprod (1997) 1.22
Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) (1993) 1.18
Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. Fertil Steril (1996) 1.11
The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin Endocrinol (Oxf) (1979) 1.08
Familial clustering in the polycystic ovarian syndrome. Gynecol Obstet Invest (1989) 1.06
Phenotype and genotype in polycystic ovary syndrome. Recent Prog Horm Res (1998) 1.04
A twin study of polycystic ovary syndrome. Fertil Steril (1995) 1.03
Familial polycystic ovaries: a genetic disease? Clin Endocrinol (Oxf) (1988) 0.98
Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive. J Clin Endocrinol Metab (1974) 0.96
Mapping diabetes-susceptibility genes. Lessons learned from search for DNA marker for maturity-onset diabetes of the young. Diabetes (1992) 0.96
Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women. J Clin Endocrinol Metab (1994) 0.90
Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (1995) 0.83
Familial hypersecretion of adrenal androgens transmitted as a dominant, non-HLA linked trait. Obstet Gynecol (1987) 0.83
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science (1997) 6.66
PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol (1999) 5.83
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab (1999) 5.28
Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology (1986) 4.89
The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem (2001) 4.74
Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation (1989) 4.32
Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest (2001) 3.41
Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A (1998) 3.35
Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science (1995) 3.29
International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet (1990) 3.29
Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases. BMJ (2000) 3.12
Pathogenicity of Helicobacter pylori: a perspective. Infect Immun (1993) 3.08
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man. Epidemiol Infect (1993) 2.94
Evaluation of computer support for prescribing (CAPSULE) using simulated cases. BMJ (1997) 2.61
The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns (1999) 2.58
Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med (2001) 2.56
Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms. Am J Clin Pathol (1986) 2.52
Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects. J Med Genet (1993) 2.50
The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem (1999) 2.45
Premature rupture of the fetal membranes. N Engl J Med (1998) 2.42
A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab (1998) 2.35
Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer (1990) 2.32
The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med (1996) 2.08
Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. Circulation (1998) 2.06
Cross-reaction of immune sera from patients with rickettsial diseases. J Med Microbiol (1989) 2.04
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet (1982) 2.01
Angelman syndrome: mimicking conditions and phenotypes. Am J Med Genet (2001) 2.00
Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab (1998) 1.97
Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA (2001) 1.90
Septic arthritis of the shoulder in adults. J Bone Joint Surg Am (1989) 1.88
Helicobacter pylori gastric infection in gnotobiotic beagle dogs. Infect Immun (1990) 1.88
The validity of criteria for the evaluation of cerebral atrophy by computed tomography. Radiology (1975) 1.87
The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev (1982) 1.86
Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol (1985) 1.85
Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J Clin Endocrinol Metab (2005) 1.84
Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol (1999) 1.84
Gene deletion and restriction fragment length polymorphisms at the human ornithine transcarbamylase locus. Nature (1985) 1.77
A comparison of socioeconomic differences in mortality between Japan and England and Wales. World Health Stat Q (1983) 1.69
Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci U S A (1999) 1.68
Proximal tubular secretion of angiotensin II in rats. Am J Physiol (1993) 1.68
Age prevalence of antibody to human herpesvirus 6. Lancet (1988) 1.66
Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet (1990) 1.64
Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy. Cancer (1993) 1.62
Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity. J Biol Chem (1997) 1.59
Pharmacomechanical coupling in smooth muscle may involve phosphatidylinositol metabolism. Proc Natl Acad Sci U S A (1984) 1.58
A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J Clin Invest (1996) 1.57
Experimental Campylobacter jejuni infection in Macaca nemestrina. Infect Immun (1989) 1.56
Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum Mol Genet (1997) 1.56
Malignant fibrous histiocytoma: an institutional review. Cancer Invest (2001) 1.54
The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab (2001) 1.54
Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats. Hypertension (1992) 1.52
Differences in mortality by housing tenure and by car access from the OPCS Longitudinal Study. Popul Trends (1995) 1.52
Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab (1987) 1.50
Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action. Proc Natl Acad Sci U S A (1996) 1.50
NPS R-568 halts or reverses osteitis fibrosa in uremic rats. Kidney Int (1998) 1.49
Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery. Int J Radiat Oncol Biol Phys (1995) 1.47
Utilization of oral hypoglycemic agents in a drug-insured U.S. population. Diabetes Care (2001) 1.45
Human steroidogenic acute regulatory protein: functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13. Proc Natl Acad Sci U S A (1995) 1.44
Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nat Genet (1996) 1.44
Implantation of a pulsatile external left ventricular assist device: role of intraoperative transesophageal echocardiography. J Cardiothorac Vasc Anesth (1994) 1.44
Mortality of employed men and women. Am J Ind Med (1991) 1.42
Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene (1994) 1.40
Alterations in the binding site of the cyclic AMP receptor protein at the Escherichia coli galactose operon regulatory region. Biochem J (1988) 1.40
Stability of ranitidine and thiamine in parenteral nutrition solutions. Nutrition (1997) 1.40
MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis. Proc Natl Acad Sci U S A (1997) 1.38
Molecular cloning of rat type 2C (IA) protein phosphatase mRNA. Proc Natl Acad Sci U S A (1989) 1.36
Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck (1995) 1.35
Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest (2000) 1.34
Potentiation of wound infection by surgical drains. Am J Surg (1976) 1.34
Sterol-modulated glycolipid sorting occurs in niemann-pick C1 late endosomes. J Biol Chem (2000) 1.33
The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients. Genet Test (1997) 1.33
Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classes. Clin Ther (2001) 1.33
An insight into early reproductive processes through the in vivo model of ovum donation. J Clin Endocrinol Metab (1991) 1.31
Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity. J Clin Endocrinol Metab (2006) 1.31
Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther (2001) 1.31
Retracted The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J Biol Chem (2001) 1.30
Niemann-Pick C1 protein: obligatory roles for N-terminal domains and lysosomal targeting in cholesterol mobilization. Proc Natl Acad Sci U S A (1999) 1.30
The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J Biol Chem (1994) 1.30
De novo synthesis of Escherichia coli glycogen is due to primer associated with glycogen synthase and activation by branching enzyme. Arch Biochem Biophys (1978) 1.28
Pulmonary complications in patients undergoing thoracotomy for lung carcinoma. Chest (1994) 1.27
92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol (1995) 1.26
Sema7A is a potent monocyte stimulator. Scand J Immunol (2002) 1.26
Steroidogenic acute regulatory protein (StAR) is a sterol transfer protein. J Biol Chem (1998) 1.26
Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest (1997) 1.26
Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures. J Infect Dis (1994) 1.24
cDNA cloning and characterization of a human sperm antigen (SPAG6) with homology to the product of the Chlamydomonas PF16 locus. Genomics (1999) 1.24
Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab (1997) 1.23
Sperm antigen 6 is the murine homologue of the Chlamydomonas reinhardtii central apparatus protein encoded by the PF16 locus. Biol Reprod (2000) 1.23
RAGs: A novel approach to computerized genetic risk assessment and decision support from pedigrees. Methods Inf Med (2001) 1.22
Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84. Bone (2008) 1.22
Human adrenodoxin: cloning of three cDNAs and cycloheximide enhancement in JEG-3 cells. J Biol Chem (1988) 1.21